2

The Value of Health – Empirical issues when estimating the monetary value of a QALY based on well-being data

In this paper we attempted to estimate a monetary value of a QALY for Germany based on data from the SOEP panel using the well-being valuation approach.

Preferences for e-Mental Health Interventions in Germany: A Discrete Choice Experiment

Electronic health interventions especially for mental health may more and more provide valuable treatment possibilities. This paper attempted to measure preferences in the general German population and mental health users towards different attributes of potential electronic heath interventions, finding that blended care formats (i.e. a combination in-person and electronic means) would be most preferred.

What works better for preference elicitation among older people? Cognitive burden of discrete choice experiment and case 2 best-worst scaling in an online setting

As a pre-study for generating population weights for a nine-dimensional well-being instrument among the eldery, we examined which type of choice experiment is less cognitively burdensome to survey respondents.

Estimating the monetary value of health and capability well‑being applying the well‑being valuation approach

We used a dataset originally collected for a different purpose to estimate the monetary value of health and capability well-being based on the well-being valuation approach.

Happy with Your Capabilities? Valuing ICECAP-O and ICECAP-A States Based on Experienced Utility Using Subjective Well-Being Data

In this first paper of my PhD project, we used an alternatve approach to estimate utility weights for two capability well-being instruments (ICECAP-A and ICECAP-O).

Willingness to pay for an early warning system for infectious diseases

This paper tries to answer the question on how much European citizens would be willing to pay for an early warning system for infectious diseases. It was part of the [COMPARE project](https://www.compare-europe.eu/about) and unfortunately is now way more topcial then anticipated when the study was conducted.

The societal impact of a biologic treatment of ankylosing spondylitis: a case study based on secukinumab

In this project, we quantified the societal economic impact of the use of a novel biologic treatment for ankolysing spondylitis in Germany.

The societal impact of obinutuzumab in the first-line treatment of patients with follicular lymphoma in Germany

This study quantifies the productivity gains associated with the use of obinutuzumab in follicular lymphoma patients, including gains in paid work and in unpaid work

A case study applying a novel approach to estimate the social impact of a medical innovation - the use of secukinumab for psoriatic arthritis in Germany

We estimated the societal impact of the use of a biologic treatment for psoriatic arthritis in Germany for the years 2016 to 2030.

Long-term health benefits of stroke prevention with apixaban versus vitamin K antagonist warfarin in patients with non-valvular atrial fibrillation in Germany: a population-based modelling study

In this project, we aggregated the societal health effects of the use of a novel anticoagulant in patients with atrial fibrillation.